Creative Biolabs

Lipid Nanoparticle Products

The landscape of gene therapy and mRNA vaccine development is rapidly evolving, yet it presents significant challenges in achieving safe and effective delivery of delicate nucleic acid payloads. Overcoming biological barriers and ensuring payload stability are critical hurdles that demand innovative solutions. Lipid nanoparticles (LNPs) have emerged as a revolutionary delivery system, offering a promising avenue to address these complexities. At Creative Biolabs, we specialize in providing advanced and ready-to-use LNP products, empowering researchers to push the boundaries of targeted drug delivery in this crucial field.

Overview

At the forefront of nucleic acid delivery, LNPs are sophisticated, self-assembling systems engineered from a precise blend of ionizable lipids, helper lipids, cholesterol, and PEGylated lipids. As a leading non-viral vector platform, LNPs are meticulously designed to encapsulate and shield delicate therapeutic payloads—such as mRNA, siRNA, and RNA-guided gene editing systems—from degradation within complex biological environments. By enabling the precise transport and efficient intracellular delivery of these molecules, LNPs effectively overcome critical biological barriers, including enzymatic breakdown in the bloodstream and the challenge of cellular membrane impermeability. This unique capability establishes LNPs as indispensable tools for pioneering research and development in gene therapy, mRNA vaccines, RNAi therapeutics, and advanced cell therapies.

Biocompatibility and Biodegradability

Composed of naturally occurring or synthetic lipids, LNPs exhibit favorable biocompatibility and are designed to degrade safely within the body, minimizing long-term toxicity.

Tunable Surface Chemistry

The surface of LNPs can be readily modified with targeting ligands (e.g., antibodies, peptides, aptamers) to achieve cell-specific or tissue-specific delivery, enhancing therapeutic precision.

The advantages of LNP. (Creative Biolabs Original)

Sustained and Controlled Release

The lipid bilayer can be engineered to release its payload over a prolonged period, prolonging the drug's half-life and achieving sustained therapeutic effects.

Versatile Payload Compatibility

LNPs can encapsulate a broad spectrum of therapeutic agents, including various nucleic acids (mRNA, siRNA, DNA plasmids, CircRNA, ASO), small molecule drugs, and certain proteins/peptides.

Explore Our Product Portfolio

View All Products

Creative Biolabs offers a diverse range of ready-to-use LNP products meticulously designed to meet the varied and evolving needs of researchers.

Empty LNP

Explore pre-formulated liposomes with agents like clodronate or doxorubicin for preclinical research.

Fluorescent LNPs

Ideal for in vitro and in vivo tracking and visualization of LNP delivery, these LNPs streamline studies of cellular uptake and biodistribution.

mRNA & CAR mRNA-LNP

Pre-formulated LNPs encapsulating mRNA or CAR mRNA, prepared for immediate use in Gene Therapy and Cell Therapy applications, including CAR-T development.

siRNA-LNP

Optimized LNPs for the efficient delivery of siRNA, enabling robust gene silencing in RNAi therapy research.

CircRNA-LNP

Novel LNP formulations engineered for the stable and efficient delivery of circular RNA, opening new avenues in advanced drug delivery.

Pep-LNP & Ab-LNP

Optimized LNPs for the efficient delivery of siRNA, enabling robust gene silencing in RNAi therapy research.

In addition to our comprehensive range of LNP products, we also provide high-quality LNP-related raw materials. These include essential components such as ionizable lipids, PEGylated lipids, helper lipids, and cholesterol, empowering researchers with the foundational elements for their custom LNP development. Contact us today to discuss your specific raw material needs and empower your custom LNP development.

Need a Custom Solution?

Request a Custom Service Consultation

Should your specific application necessitate a unique product, or if a novel combination of LNP products and functionalities is required, our custom development services provide the definitive answer. We engage in collaborative partnerships to transform your innovative concepts into tangible, high-performance delivery solutions.

Nucleic Acid Synthesis & Modification

Specialized services for the synthesis of high-quality nucleic acids, including various modifications such as Cap1, N1-methyl-pseudouridine, and 5-methoxyuridine, to optimize stability and translation efficiency for LNP encapsulation.

Customized LNP Formulation

Clients can specify their desired LNP formula or request custom formulations developed based on specific literature references, ensuring precise control over composition.

Customizable LNP Concentration

While our default LNP concentration is 0.2 mg/ml, clients can specify their desired concentration to meet the precise requirements of their experimental setup.

High-Throughput Screening of LNP

Utilizing advanced screening platforms to rapidly identify optimal LNP formulations for specific payloads and cell types, accelerating LNP development.

Custom Payload Encapsulation

Specialized services for encapsulating a wide array of therapeutic payloads, including mRNA and other nucleic acid drugs.

Conjugation Strategy Design

Expert guidance and execution for the attachment of targeting ligands (e.g., aptamers, peptides, antibodies) for enhanced Targeted delivery, encompassing Aptamer-conjugated LNP and Peptide-conjugated LNP.

Characterization

Rigorous analytical services (e.g., size, PDI, zeta potential, drug loading) for LNP characterization to comprehensively evaluate your LNP formulations.

Targeting Verification

Comprehensive support for assessing the efficacy and safety of your custom delivery systems, including in vitro and in vivo studies across various cell and animal models, assisting clients in biological distribution and other research objectives, and ensuring high transfection efficiency in cell transfection.

Case Study

All

mRNA-LNP

Case study-Fluc mRNA-LNP. (Creative Biolabs Original)

Fluc mRNA-LNP

  • Size: 99.07 nm
  • PDI: 0.149
  • Zeta Potential: -5.36 mV
  • Encapsulation Efficiency: 99.95%

Applications of LNP

Applications of our advanced LNP. (Creative Biolabs Authorized)
  • mRNA Vaccines: LNPs form the foundational backbone for the development of highly effective mRNA vaccine candidates for infectious diseases (e.g., COVID-19) and are actively being explored for cancer immunotherapies.
  • Gene Therapy: Facilitating the intracellular delivery of genetic material for precise genomic modifications in therapeutic applications.
  • RNAi Therapy: Enabling the targeted delivery of siRNA and shRNA molecules for gene silencing in diverse disease contexts.
  • Cell Therapy: Crucial for delivering genetic payloads for cell transfection in applications such as CAR-T cell engineering, thereby ensuring high transfection efficiency.
  • Oncology Drug Delivery: Facilitating the precise delivery of chemotherapeutics, immunomodulators, or nucleic acids specifically to tumor cells, which enhances efficacy and mitigates systemic toxicity, including Oncology drug delivery LNP.
  • Nucleic Acid Delivery: Providing a robust platform for the efficient delivery of various nucleic acids, such as mRNA, siRNA, circRNA, and ASO, for diverse therapeutic strategies.
  • Therapeutic LNP: Utilizing LNPs for a broad spectrum of therapeutic applications beyond nucleic acids, encompassing protein and peptide delivery.

Why Choose Creative Biolabs?

Product Ordering Process

Process of placing an order. (Creative Biolabs Original)

FAQs

What types of payloads can Creative Biolabs' LNP products deliver?

Our LNP products accommodate a vast array of payloads, including mRNA, siRNA, CircRNA, ASOs, DNA plasmids, CRISPR components, small molecules, proteins, and peptides, supporting diverse Drug encapsulation LNP needs.

How does Creative Biolabs ensure product quality?

Creative Biolabs adheres to stringent quality control throughout manufacturing. Our LNP products undergo rigorous LNP characterization (size, PDI, zeta potential, encapsulation efficiency) to guarantee high purity, stability, and consistent performance.

What is the typical turnaround time for custom LNP orders?

Turnaround times vary based on complexity and scale. Please contact our technical support team with your specific requirements for a detailed timeline estimate.

Do you offer technical support for LNP product usage?

Yes, our experienced scientific team provides comprehensive technical support to assist with product selection, experimental design, and troubleshooting to ensure successful LNP applications.

Can Creative Biolabs assist with in vivo studies?

We offer in vitro and in vivo targeting verification services, including studies across various cell and animal models, to help clients assess the efficacy and biodistribution of their custom LNP delivery systems.

Filter:

[CAT#: TDLD-0126-LD138]
SS31 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD49]
BCMA CAR mRNA-LNP
Payload Type: CAR mRNA
Module Type: Unconjugation
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Gene Therapy; CAR-T
[CAT#: TDLD-0126-LD95]
GPLGVRGC Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD80]
iRGD Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD101]
Glutathione (GSH) Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD92]
CTP Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD103]
HP2 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD66]
Targeted CD5 Ab-LNP
Payload Type: mRNA
Module Type: Antibody
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD35]
RET CAR mRNA-LNP
Payload Type: CAR mRNA
Module Type: Unconjugation
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Gene Therapy; CAR-T
[CAT#: TDLD-0825-LD79]
RGD Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD150]
VLWLKNR Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD156]
CREKA Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD70]
YIGSR Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD87]
Asp8 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD99]
EB1 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD67]
Targeted CD7 Ab-LNP
Payload Type: mRNA
Module Type: Antibody
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD95]
FSHB Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD120]
NR7 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD142]
THRPPMWSPVWP Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD47]
GPC3 CAR mRNA-LNP
Payload Type: CAR mRNA
Module Type: Unconjugation
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Gene Therapy; CAR-T
[CAT#: TDLD-0126-LD118]
MPP Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD140]
TAASGVRSMH Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD84]
E7 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD62]
mCherry CircRNA-LNP
Payload Type: CircRNA
Module Type: Unconjugation
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Tracking & Imaging; Gene Therapy
[CAT#: TDLD-0126-LD57]
Targeted CD8 Ab-LNP
Payload Type: mRNA
Module Type: Antibody
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD136]
SHp Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD100]
GRGDSPC Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD44]
HER3 CAR mRNA-LNP
Payload Type: CAR mRNA
Module Type: Unconjugation
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Gene Therapy; CAR-T
[CAT#: TDLD-0126-LD128]
PH1 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD130]
(Arg)8 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD158]
KLVFF Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD125]
Pep-1 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD92]
GLP-1 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD103]
KAA Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD151]
VTLTYEFAAGPRD Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD16]
Gluc mRNA-LNP
Payload Type: mRNA
Module Type: Unconjugation
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Tracking & Imaging; Gene Therapy
[CAT#: TDLD-0825-LD57]
CS1 CAR mRNA-LNP
Payload Type: CAR mRNA
Module Type: Unconjugation
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Gene Therapy; CAR-T
[CAT#: TDLD-0825-LD59]
β-Gal CircRNA-LNP
Payload Type: CircRNA
Module Type: Unconjugation
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Tracking & Imaging; Gene Therapy
[CAT#: TDLD-0825-LD93]
PCM Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD122]
Ovalbumin Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD20]
Cre mRNA-LNP
Payload Type: mRNA
Module Type: Unconjugation
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Tracking & Imaging; Gene Therapy
[CAT#: TDLD-0126-LD115]
LyP-1 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD114]
LXW7 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD117]
MMP9 Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD96]
GPLGVRGK Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD68]
Targeted CD34 Ab-LNP
Payload Type: mRNA
Module Type: Antibody
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD33]
CD22 CAR mRNA-LNP
Payload Type: CAR mRNA
Module Type: Unconjugation
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Gene Therapy; CAR-T
[CAT#: TDLD-0126-LD111]
LPFFD Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0126-LD102]
HGGVRLY Pep-LNP
Payload Type: mRNA
Module Type: Peptide
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Control; Targeted Delivery; Gene Therapy
[CAT#: TDLD-0825-LD32]
CD20 CAR mRNA-LNP
Payload Type: CAR mRNA
Module Type: Unconjugation
Modification: Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
Application: Gene Therapy; CAR-T
Online Inquiry

Customer Review

Creatibe Biolabs' custom LNP was the only solution that successfully delivered our CRISPR-Cas9 payload across the blood-brain barrier with high efficiency and low toxicity.”

Dr. Evelyn Reed

Postdoctoral Researcher, Leading University

Our siRNA candidate was failing due to off-target toxicity, but Creatibe Biolabs' team rapidly redesigned our LNP using their modular platform, rescuing our preclinical program.”

Ben Carter

Project Manager

Achieving cytosolic delivery of our protein degrader with Creatibe Biolabs' exosome platform was the key to unlocking our candidate's full therapeutic potential.”

Dr. Kenji Tanaka

Principal Scientist, Large Pharma Corp

Our oncology drug's efficacy was limited by poor tumor accumulation. Creatibe Biolabs' peptide-conjugated liposomes provided the precise targeting we needed, dramatically increasing the drug's therapeutic index.”

Dr. Clara Schmidt

Senior Scientist, Oncology Innovations Inc.

We required a delivery system that would only release its payload in the tumor's acidic microenvironment. Creatibe Biolabs' pH-responsive liposomes performed flawlessly, minimizing systemic exposure.”

David Chen

Formulation Scientist

Outstanding expertise in antibody engineering.The team's attention to detail and innovative approaches have sianificantly accelerated our development timeline.

Sarah L.

Senior Research Scientist

Contact us for more information Get free consultations